Chest wall resection for internal mammary lymph node metastases of breast cancer

AN Geel, MW Wouters, C van der Pol, Paul Schmitz, T (Titia) Lans

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)


Evaluation of morbidity, mortality and oncologic outcome of patients treated with a chest wall resection for isolated breast cancer recurrences in the Internal Mammary Chain. Retrospectively we retrieved data front 29 patients. Multivariate analysis was performed to identify prognostic factors for (disease-free) survival. There were no postoperative deaths. Complications Occurred in I I patients. The median follow-up after CWR for all 16 patients still alive at the end of this Study is 18.4 months. Nine patients were free of cancer. The 3-year overall and disease-free survival is 59.2% and 8.6%. The median survival is 40.7 months. After multivariate analysis for each of the four endpoints studied, only one prognostic factor remains significant for survival: systemic therapy before CRW (p=0.004). For local recurrence-free survival a first CRW recurrence (p < 0.00001) and for disease-free Survival radicality of the resection (p = 0.008) are independent prognostic factors. Chest wall resection is a safe and effective treatment for isolated breast cancer recurrences in the IMC. Surgically treated patients have a fair survival and some of them are even cured. (C) 2009 Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)94-99
Number of pages6
Issue number2
Publication statusPublished - 2009

Research programs

  • EMC MM-03-47-11

Cite this